KBC Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-23,962
Closed -$1.92M 1363
2016
Q4
$1.92M Buy
23,962
+3,638
+18% +$289K 0.02% 641
2016
Q3
$1.62M Buy
20,324
+805
+4% +$65K 0.02% 632
2016
Q2
$1.52M Sell
19,519
-626
-3% -$44.6K 0.02% 596
2016
Q1
$1.11M Sell
20,145
-3,832
-16% -$209K 0.02% 629
2015
Q4
$1.48M Sell
23,977
-42,558
-64% -$2.68M 0.03% 536
2015
Q3
$4.2M Buy
66,535
+44,274
+199% +$3.16M 0.08% 287
2015
Q2
$1.63M Sell
22,261
-5,720
-20% -$413K 0.02% 609
2015
Q1
$1.83M Sell
27,981
-14,734
-34% -$980K 0.02% 573
2014
Q4
$2.78M Buy
42,715
+30,307
+244% +$1.95M 0.03% 507
2014
Q3
$746K Sell
12,408
-47,867
-79% -$3.13M 0.03% 620
2014
Q2
$4.17M Sell
60,275
-61,955
-51% -$4.02M 0.05% 421
2014
Q1
$7.99M Buy
122,230
+85,955
+237% +$5.6M 0.13% 211
2013
Q4
$2.25M Sell
36,275
-6,658
-16% -$386K 0.03% 488
2013
Q3
$2.3M Sell
42,933
-1,758
-4% -$90.5K 0.04% 477
2013
Q2
$2.04M Buy
+44,691
New +$1.94M 0.04% 490

Other funds holding STJ

KBC Group's STJ Position: Q1 2017 in Review

KBC Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 23,962 shares — an estimated $1.92M sold.

KBC Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $7.99M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • KBC Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • KBC Group sold 23,962 St Jude Medical shares in Q1 2017, an estimated $1.92M.
  • KBC Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • KBC Group's St Jude Medical position peaked at $7.99M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.